SCHEMBL12818236

SCHEMBL12818236

N#Cc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2cc4ccccc4s2)CCO3)cs1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 2/20 0.35
▸ PDE3A Q14432 2/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ KMT2A Q03164 6/20 0.34
▸ MEN1 O00255 5/20 0.34
▸ CPT1A P50416 3/20 0.34
▸ CPT1B Q92523 3/20 0.34
▸ NR1H3 Q13133 1/20 0.33
▸ MAPT P10636 4/20 0.33
▸ USP30 Q70CQ3 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ USP2 O75604 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818855 0.86 PGR (0.36) PDE3BPDE3ANPC1KMT2AMEN1
SCHEMBL1817593 0.85 NR1H3 (0.46) NPC1KMT2AMEN1CPT1ACPT1B
SCHEMBL12817588 0.84 PDE3B (0.35) PDE3BPDE3ANPC1KMT2AMEN1
SCHEMBL12817586 0.84 PDE3B (0.40) PDE3BPDE3AKMT2AMEN1MAPT
SCHEMBL12818659 0.83 PIK3CD (0.42) PDE3BPDE3AKMT2AMEN1MAPT
SCHEMBL12817574 0.83 RORC (0.34) CPT1ACPT1BNR1H3CA2
SCHEMBL12818203 0.83 PDE3B (0.37) PDE3BPDE3ANPC1KMT2AMEN1
SCHEMBL12818152 0.82 MEN1 (0.38) PDE3BPDE3ANPC1KMT2AMEN1
SCHEMBL1821637 0.80 PKM (0.48) NPC1KMT2AMEN1CYP2C9ALDH1A1
SCHEMBL1819206 0.79 PKM (0.42) PDE3BPDE3ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback